Ursane type triterpenoid saponin compound as well as preparation method and application thereof
A technology of triterpenoid saponins and ursane type, applied in the preparation of drugs for the treatment of inflammatory vascular diseases, in the field of pentacyclic triterpenoids, can solve the problems of unsatisfactory anti-inflammatory activity of triterpenoid saponins
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0036] 1. Preparation of compounds
[0037] (1) Get the roots of Ilex pubescens, reflux extraction with 12, 10 and 8 times of 70% ethanol successively for 2 hours, combine the ethanol extracts, recycle the ethanol after filtration and concentrate under reduced pressure until there is no alcohol smell, to obtain the total extract 2.2 kg;
[0038] (2) total extract is dissolved in water, cross D-101 type macroporous resin column, be that 30% ethanol with concentration, 60% ethanol and 95% ethanol with concentration are eluted successively; Collection concentration is 60% % ethanol eluent was recovered under reduced pressure to obtain 566g thick extract, which was passed through a 200-300 mesh silica gel column, and carried out with chloroform-methanol as the solvent according to the gradient of 100:1-0:1 in chloroform:methanol Elution; collect the eluate with chloroform:methanol ratio of 85:15, concentrate and pass through the Sephadex LH-20 column, use methanol as the eluent t...
example 2
[0048] Example 2: (injection)
[0049] Take 1000 mg of the compound obtained by the method described in Example 1 above, add 1000 ml of water for injection, adjust the pH value to 7-7.5 with sodium carbonate, stir to dissolve, sterilize and filter, potting, and circulate steam at 100 ° C for 15 minutes Sterilize and make each 2mg / 2ml injection for injection.
example 3
[0050] Example 3: (capsules)
[0051] Take the compound 5000mg obtained by the method described in the above-mentioned Example 1 and fully mix with auxiliary materials such as 4000mg microcrystalline cellulose, 500mg sodium carboxymethyl starch, 400mg sodium lauryl sulfate, and carry out dry granulation by roller compaction, and then mix with An appropriate amount of magnesium stearate is mixed, filled into 3# hollow capsules, and made into capsules with a specification of 100 mg / grain for oral use.
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com